$HCA

HCA’s bottom line suffers as ACA coverage losses mount

HCA Healthcare reported a $400 million pretax earnings hit in Q3 due to rising uninsured admissions, now at 10.5% of its volume. Executives expect losses to exceed the previously forecasted $1.2 billion. This follows a trend of patients dropping ACA coverage due to premium increases, with 4.6 million fewer enrollees in June 2026 vs. 2025. HCA, a bellwether for for-profit hospitals, has lost $950 million in pretax earnings this year.

Original reporting
Published Oct 28, 2026, 2:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 3:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
HCA’s bottom line suffers as ACA coverage losses mount — source image
Decision brief

The 30-second read

$HCABearishHigh
01

Why it matters

The disclosed ACA‑related loss guidance is the first detailed quantification of the uninsured surge impact on earnings.

02

Market read

New guidance suggests a material earnings downgrade, likely prompting a sell‑off in HCA and related healthcare stocks.

03

What to watch

Potential cost‑containment measures or government subsidies could mitigate future losses.

Relevance 8/10Novelty 8/10Timing: after‑hours reaction

Background

HCA is a bellwether for for‑profit hospitals, operating 190 hospitals and 2,600 care sites in the U.S. and U.K.

Company-level read

Ticker impact

$HCABearishHigh confidence
Context

HCA disclosed a $400 million pretax earnings hit in Q3 and raised its expected ACA‑related loss to over $1 billion, a fresh guidance cut.

Expected impact

downward pressure as investors price in larger-than‑expected losses

Evidence & confidence

Guidance cut of >$1 billion is material for a large hospital operator and likely triggers sell‑offs.

Market effects

For‑profit hospital sector may see broader earnings pressure as uninsured volume rises.

U.S. healthcare stocks could face short‑term weakness.

Limited to U.S. markets; no immediate global ripple.

Counterpoint

If uninsured patients shift to other payers later, the loss impact could be temporary.

Key entities

  • HCA Healthcare

    Largest U.S. for‑profit hospital operator.

Related articles

$HCAMed

BofA raises HCA Healthcare stock price target on solid execution

BofA Securities raised its price target on HCA Healthcare (NYSE:HCA) to $500 from $450, citing solid execution and upside from supplemental Medicaid programs. The company's Q3 EBITDA exceeded estimates, with revenue of $19.85B and EPS of $7.22. HCA maintained its guidance range but faces near-term headwinds. The stock trades at an EV/EBITDA of 9.6x and a P/E ratio of 14.85.

$HCAMed

HCA Healthcare Inc (HCA) Q3 2026 Earnings Call Highlights: 22 Straight Quarters

HCA Healthcare (HCA) reported Q3 2026 earnings, highlighting a 19% decline in exchange equivalent admissions, a $400M unfavorable EBITDA impact, and reduced elective surgical volumes. The company expects $550M-$650M less in Medicaid supplemental payments in 2027. HCA anticipates 2027 earnings to be generally consistent with 2026, citing exchange headwinds and reduced supplemental payments.

$HCAMedAI 8/10

What HCA Healthcare (HCA) Said on Its Q3 Earnings Call

HCA Healthcare reported $50M in incremental Medicaid benefits in Q3, raising its 2026 estimate to $600M-$800M. Costs were flat, but professional fees rose 12%. HCA reaffirmed 2026 guidance, expecting upper-half results. For 2027, it anticipates strong demand and earnings similar to 2026. The company spent $1.36B on capital expenditures, repurchased $3B in shares, and paid $165M in dividends.

$HCAHighAI 9/10

HCA (HCA) Q3 2026 Earnings Call Transcript

HCA Healthcare reported Q3 2026 revenue of $19.849 billion, up 3.6% YoY, with net income of $1.579 billion. EPS grew 4.4% to $7.27. Adjusted EBITDA rose 1.2% to $3.918 billion. Volume growth continued, but payer mix shifts impacted earnings. The company raised full-year revenue and EBITDA guidance. Management expects stable 2027 earnings despite Medicaid payment headwinds.

$HCAHighAI 8/10

HCA signals flat 2027 earnings as Medicaid payments drop; shares slide

HCA Healthcare forecasted flat 2027 earnings, citing lower Medicaid payments and rising uninsured patients, causing shares to drop over 5%. CEO Sam Hazen attributed the outlook to a fluid policy environment. Analysts expect 2027 EPS of $32.14, below the company's implied guidance. HCA's Q3 adjusted profit was $7.22 per share on revenue of $19.85 billion, beating estimates. The company expects 2026 EPS between $28.70 and $30.50 on revenue of $77.0B-$79.5B.